Sasoter, Maricar .

HRN: 11-51-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2022
CEFUROXIME 750MG (VIAL)
06/17/2022
06/24/2022
IV
750 Mg
Q8
UTI
Waiting Final Action 
11/21/2022
CEFTRIAXONE 1G (VIAL)
11/21/2022
11/28/2022
IV
1gm
Q12
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: